Flinton Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Flinton Capital Management's PFE Position: Q3 2019 in Review
Flinton Capital Management reduced its Pfizer (PFE) stake by 16% in Q3 2019, selling an estimated $3.96M and leaving 552,642 shares worth $18.8M. The position accounts for 0.58% of the portfolio, ranked #31.
Flinton Capital Management first reported a position in PFE in Q4 2016 and has held it in 12 quarters since. The position peaked at $29.1M in Q1 2019. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.
- Flinton Capital Management held 552,642 shares of Pfizer worth $18.8M as of Q3 2019.
- Flinton Capital Management sold 108,810 Pfizer shares in Q3 2019, an estimated $3.96M.
- Pfizer made up 0.58% of Flinton Capital Management's portfolio in Q3 2019, its #31 holding.
- Flinton Capital Management first reported a position in Pfizer in Q4 2016 and has held it in 12 quarters since.
- Flinton Capital Management's Pfizer position peaked at $29.1M in Q1 2019.
- 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.
Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.